IntelleWave is a non-invasive cardiac monitoring device that provides Quantitative assessment of the Autonomic Nervous System (ANS) on the basis of Heart Rate Variability (HRV) and blood pressure analysis. The system is used to objectively confirm or exclude a Cardiovascular Autonomic Neuropathy (CAN), a Diabetic Autonomic Neuropathy (DAN) and other dysautonomia problems. It is able to quantitatively distinguish between the early and the chronic stages of autonomic neuropathy. Intellewave also can provide "real-time" up to 24hr quantitative ANS assessment. The list of potential application by this regime is next:
- Monitor ANS status during anesthesia.
- Monitor ANS status in intensive care to see effectiveness of medication.
- Monitor ANS status by implantable devices.
- Using for sleep studies to see the difference between "sleep time" and
  "awake time".   read more >>>